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Background: It is widely believed that females have longer telomeres than males, although results from studies
have been contradictory.
Methods:We carried out a systematic review and meta-analyses to test the hypothesis that in humans, females
have longer telomeres than males and that this association becomes stronger with increasing age. Searches
were conducted in EMBASE and MEDLINE (by November 2009) and additional datasets were obtained from
study investigators. Eligible observational studies measured telomeres for both females and males of any age,
had a minimum sample size of 100 and included participants not part of a diseased group. We calculated
summary estimates using random-effects meta-analyses. Heterogeneity between studies was investigated
using sub-group analysis and meta-regression.
Results:Meta-analyses from 36 cohorts (36,230 participants) showed that on average females had longer telo-
meres than males (standardised difference in telomere length between females and males 0.090, 95% CI 0.015,
0.166; age-adjusted). There was little evidence that these associations varied by age group (p = 1.00) or cell
type (p = 0.29). However, the size of this difference did vary by measurement methods, with only Southern
blot but neither real-time PCR nor Flow-FISH showing a significant difference. This difference was not associated
with random measurement error.
Conclusions: Telomere length is longer in females than males, although this difference was not universally found
in studies that did not use Southern blot methods. Further research on explanations for the methodological
differences is required.© 2013 Published by Elsevier Inc.1. Introduction
Telomeres are nucleoprotein complexes at chromosome ends,
where the DNA component is a repetitive stretch of (TTAGGG), which
caps and protects the end of the chromosome. Some studies have
found that shorter telomeres are associated with obesity (Nordfjall
et al., 2008a), gender (Bekaert et al., 2007), lower socioeconomic
position (Cherkas et al., 2008), smoking (Valdes et al., 2005) and
mortality (Cawthon et al., 2003). Hence telomere length has been
proposed as a useful index of biological age (Hunt et al., 2008), although
this has been called into question (von Zglinicki, 2012). The present
study focuses on the association with gender.
In the literature there are inconsistencies in the association between
gender and telomere length. Some studies (Nawrot et al., 2004; Bekaert
et al., 2007; Fitzpatrick et al., 2007) have found white blood cell
telomeres to be longer in women than men. Several hypotheses have
been postulated to explain this association (Nawrot et al., 2004;
Mayer et al., 2006; Barrett and Richardson, 2011). One is the action of
oestrogen (Mayer et al., 2006). An oestrogen-responsive element is
present in telomerase reverse transcriptase (hTERT) (Nawrot et al.,
2004), hence oestrogen might stimulate telomerase to add telomere
repeats to the ends of chromosomes. Furthermore, telomeres are partic-
ularly sensitive to oxidative stress (von Zglinicki, 2002) and women
produce fewer reactive oxygen species than men (Nawrot et al.,
2004). It has been suggested thatwomenmight alsometabolise reactive
oxygen species better because of oestrogen (Nawrot et al., 2004), due to
its antioxidant properties (Carrero et al., 2008). However, other studies
have found that it is not always the case that telomere length is longer in
females than males (Hunt et al., 2008; Shiels et al., 2011) or even the
reverse (Adams et al., 2007). At birth, one study found that there was
little difference in telomere length between the sexes (Okuda et al.,
2002), but another study found that female newborns had longer telo-
meres than males (Aubert et al., 2012). In another study, (Hunt et al.,
2008) no difference was detected in the telomere length of women
and men in the younger Bogalusa Heart Study cohort (19–37 years),
but in the older Family Heart Study cohort (30–93 years) telomeres
were longer in women than men. Hence the association between
gender and telomere length might vary by age. Whilst telomere length
is inversely related to chronological age in humans (Shiels et al., 2011),
there are concerns about how robust telomere length is as a biomarker
of ageing (Shiels, 2010; Shiels et al., 2011).
Existing studies of the association of gender and telomere length in
humans have a number of limitations. For example, some of the studies
are small e.g. (Benetos et al., 2001) and hence may not have sufficientpower to detect gender differences in telomere length. Furthermore,
there are methodological differences between assay methods (Aviv
et al., 2006), with Southern Blot providing a mean terminal restriction
length for DNA fragments containing the telomeric DNA stretch plus
sub-telomeric regions of variable length and sequence composition
and real-time PCR measuring actual telomere -repeat length relative
to a reference gene (Aviv et al., 2006). The most frequent cell types
used in studies on telomere length are either whole blood (leukocytes
made up of lymphocytes, monocytes and granulocytes) or peripheral
blood mononuclear cells (PBMCs made up of lymphocytes and
monocytes). In adults, lymphocytes have shorter telomeres than
granulocytes (Aviv et al., 2006), hence it is important to assess whether
the association between gender and telomere length varies by cell type.
A literature search and qualitative meta-analysis (Barrett and
Richardson, 2011) found that at a qualitative level, males tended to
have shorter telomeres than females. However, no systematic review
of the literature has been done to examine the association between
gender and telomere length.
We carried out a systematic review and meta-analyses to test the
hypothesis that in human populations females have longer telomeres
than males and that this association becomes stronger with increasing
age. Furthermore, we also investigated whether the association
between gender and telomere length varied by method of measure-
ment of telomere length or cell type. Our study has several advantages
over the earlier review: (a) our study is a systematic review and
meta-analysis; (b) has standardised effect estimates; (c) has more
rigorous methodology including exploration of sources of heterogene-
ity. We hypothesised that there would be an association between
gender and telomere length, with females having longer telomeres
than males and that this association would become stronger with
increasing age.
2. Methods
Weundertook a systematic review of the published literature follow-
ing themeta-analysis of observational studies in epidemiology (MOOSE)
guidelines (Stroup et al., 2000) and the PRISMA statement (Moher et al.,
2009) and we include a completed PRISMA checklist (Supplementary
Data 1). Full review protocol is available in Supplementary Data 2.
2.1. Selection criteria
Eligible observational studies had aminimumnumber of 100 partic-
ipants and measures of telomere length for both males and females.
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old) who were community dwelling at time of measurement of
telomere length and who were not part of a diseased group (including
healthy controls from case-control studies). Hence we excluded cancer
tissue studies with measurements of telomere length and those control
participants who were recruited from hospital in-patients.2.2. Literature search and data extraction
Searches of the electronic databases MEDLINE and EMBASE (up to
November 2009) were performed using text word search terms and
explosion MeSH terms (Supplementary Data 2) by MG. Searches were
restricted to studies of humans. Fig. 1 shows the identification of
published studies. Combining the results of the MEDLINE and EMBASE
electronic searches and removing duplicate records left abstracts of
6822 unique records to be screened by three authors (DB, MG and
LW). Each of the three authors (DB, MG and LW) were responsible for
screening one-third of the titles and abstracts of these 6822 papers
and any considered to be ‘uncertain’ were independently screened by
a second author. Sixty-one research papers were retrieved for full data
extraction using a standardised data extraction form. Two authorsPage 
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data of relevance from each of the 61 papers and any differences
between the two sets of information extracted were resolved through
discussion. The standardised data extraction included methods of
measurement of telomere length, cell type, details of measurement
error, details of sample recruitment, descriptive characteristics and
unadjusted, age-adjusted and fully-adjustedmeasurements of differences
in telomere length between females and males.2.2.1. Data requested from eligible studies
We contacted the corresponding authors of the 61 eligible published
research papers and asked them to complete standardised results tables
or provide the data for us to analyse (Supplementary Data 3). We
requested the regression coefficient representing the age-adjusted
difference in telomere length between females and males, along with
corresponding standard error. We asked that the study authors
calculate regression coefficients using linear regression with raw
telomere length as the outcome variable. We also requested that the
study authors provide themean age and telomere length (plus standard
deviations) of males, females and total sample. After sending out one
reminder, we received responses from 24 of the published research30
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standard sets of results and authors of another 7 research papers
provided datasets for us to analyse.
2.3. Inclusion of other studies
2.3.1. HALCyon cohort studies
We included unpublished data from three of the nine UK cohort
studies involved in the HALCyon collaboration. These were the
Hertfordshire Ageing Study (HAS) (Syddall et al., 2010), the Lothian
Birth Cohort 1921 (LBC1921) (Deary et al., 2004) and theMRC National
Survey of Health and Development (NSHD) (Kuh et al., 2011). These
studies had telomere length data available at two time points up to
10 years apart.
2.3.2. Other relevant studies
We contacted the corresponding author of an additional study
identified through the literature search (Yamaguchi et al., 2005)
which included at the time unpublished reference group telomere
length data. The corresponding author subsequently provided us with
the published reference group telomere length data (Aubert et al.,
2012) for both granulocytes and lymphocytes. Furthermore, following
e-mail contact with the corresponding authors of the 61 eligible pub-
lished research papers, the corresponding authors of two unpublished
studies: HyperGEN (Mangino et al., 2012) and the PREVEND Study
(Huzen et al., 2011) contributed datasets (two from the HyperGEN
study). An additional study (Newcastle 85+ study (Martin-Ruiz et al.,
2011)) was identified through the HALCyon collaboration (www.
halcyon.ac.uk) and a further study (The West of Scotland Twenty-07
Study (Der et al., 2012)) was identified through the FALCon collabora-
tion (www.nshd.mrc.ac.uk/collaborations/falcon.aspx). The West of
Scotland Twenty-07 Study contributed three datasets. Corresponding
authors of the HyperGEN (Mangino et al., 2012), PREVEND (Huzen
et al., 2011), Newcastle 85+ (Martin-Ruiz et al., 2011) and The West
of Scotland Twenty-07 (Der et al., 2012) studies provided us with stan-
dard sets of results and each of these studies are now published. Hence
these other relevant studies contributed an additional nine datasets
from five separate studies.
So in total there are 40 datasets (28 datasets from published
searches; 9 datasets from other relevant studies and 3 unpublished
Halcyon cohort studies) from 32 separate studies.
2.4. Telomere length measures
Telomere length was measured by terminal restriction fragment
(TRF) Southern Blot, real-time PCR or Flow-FISH (Aviv et al., 2006) in
the eligible studies. Flow-FISH is a cytogenetic technique requiring
intact cells to quantify the length of telomeres (Aviv et al., 2006). Cell
types were whole blood, peripheral blood mononuclear cells (PBMC),
lymphocytes or granulocytes (Aviv et al., 2006). Whole blood (leuko-
cytes) cells weremade up of lymphocytes, monocytes and granulocytes.
These were prepared by red cell lysis and/or centrifugation of whole
blood without Ficoll (buffy coat). PBMC (lymphocytes and sometimes
variable fraction of monocytes)were prepared bywhole blood centrifu-
gation through a Ficoll cushion or gradient. Lymphocytes or granulo-
cytes were used when specific cell fractions were isolated during the
Flow-FISH method.
2.5. Statistical methods
We performed a two stage meta-analysis. Firstly equivalent models
were run within each cohort. This involved using linear regression
models to analyse the association between gender and telomere length
adjusted for age. We made males the baseline group so that the regres-
sion coefficient represented the difference in telomere length for
females compared to males. Some studies measured absolute telomerelength in kb and others measured Telomere-to-Single Copy Gene (T/S)
ratio (Real-time PCR). Furthermore, those laboratories using Real-time
PCR methodology might use different reference samples (Horn et al.,
2010) and also might change their reference sample when it runs out.
To overcome such differences we standardised the regression coeffi-
cients (and corresponding standard error) by dividing both regression
coefficient and standard error by the standard deviation of telomere
length.
Secondly, the cohort specific standardised regression coefficients
and standard errors were pooled using random effects meta-analyses
(DerSimonian and Laird, 1986). We ran meta-analyses on results from
models with age-adjusted as a continuous term and then from models
with age-adjusted in quartiles.We included data from36datasets (pub-
lished and unpublished studies) in our meta-analyses and included the
remaining four datasets in sensitivity analyses. This was because two
studies (Aubert et al., 2012; Halaschek-Wiener et al., 2008) had data
on both granulocytes and lymphocytes and two studies (Nordfjall
et al., 2008a,b) included the MONICA cohort study which was part of
the more recent NSHDS cohort study which also included the VIP and
MSP cohort studies (Nordfjall et al., 2009). Hence we wanted to make
sure that the same sample was not included more than once within a
meta-analysis. Furthermore, the 3 HALCyon studies and another study
(Nordfjall et al., 2009) had repeat telomere length measures (time 1
and time 2). We thus ran meta-analyses first including these studies
at time 1 and then including these four studies at time 2.We investigat-
ed between study heterogeneity using I2 and Q statistics (Higgins and
Thompson, 2002; Higgins et al., 2003). We examined potential sources
of heterogeneity for age group (above versus below the median age),
method of measurement of telomere length and cell type by stratifying
random effects meta-analyses by each of these factors and by running
meta-regression analyses (Thompson and Sharp, 1999). For meta-
regression analyses, we used post-estimation Wald tests to obtain F
ratios and p values. To address non-linearity and variation with age
we undertook a meta-regression of effect size on mean age and tested
a quadratic or cubic relationship.We used funnel plots to assess publica-
tion bias and tested the symmetry of the funnel plots using Egger's test
(Egger et al., 1997).
We undertook a series of sensitivity analyses: (1) for the studies
where we had access to the dataset, we repeated the test of association
between gender and telomere length using transformed telomere
length data (loge) and compared this to the results from meta-analysis
using raw data for telomere length, to address the issue of positive
skewness in telomere length measurements; (2) we excluded those
studies where there was no detail of how the healthy participants
were sampled and repeated the meta-analyses; (3) we repeated analy-
ses using lymphocyte data rather than granulocyte data for two studies
(Aubert et al., 2012; Halaschek-Wiener et al., 2008); (4) we replaced
results from (Nordfjall et al., 2009) with data from either (Nordfjall
et al., 2008a) or (Nordfjall et al., 2008b) to avoid using the same study
population inmeta-analysesmore than once and repeated the analyses;
(5) we repeated meta-analyses including only those studies who
reported intra-assay or inter-assay coefficient of variation (CV);
(6) we repeated meta-analyses having excluded those studies
which had telomere length measured by any laboratory which ap-
peared to have outlier values.
2.6. Methodological checks
As the data from the Newcastle group contributed to the apparent
heterogeneity, a series of post hoc methodological checks was per-
formed by this group.
3. Results
Forty datasets contributed results to this review. Table 1 presents the
characteristics of these studies. Three studies (Hunt et al., 2008; Chen
Table 1
Characteristics of studies included in the reviewa.
Reference and study name or
recruitment method
Number of participants
males females
Age males
females
Telomere length
males female
Method to measure
telomere length
Cell type
Published studies from searches
Adams et al. (2007) 108 50 (−) 5.55 kb (1.25) Real-time PCR PBMC
NewcastleThousand Families Study, UK 172 50 (−) 4.69 kb (1.02)
Aubert et al. (2012) 405 43.6 (29.9) 7.97 kb (1.59) Flow-FISH Granulocytes
Healthy controls
No details of how recruited, Canada
403 43.6 (30.0) 8.09 kb (1.52)
Aubert et al. (2012) 421 43.6 (29.9) 6.95 kb (2.07) Flow-FISH Lymphocytes
Healthy controls
No details of how recruited, Canada
414 43.6 (30.0) 7.26 kb (2.04)
Bekaert et al. (2007) 1218 46.1 (5.9) 7.79 kb (0.71) TRF Southern Blot Whole blood
Asklepios study cohort, Belgium 1291 45.9 (6.0) 7.96 kb (0.73)
Bischoff et al. (2006) 260 80.5 (7.4) 7.54 kb (1.15) TRF Southern Blot Whole blood
The Danish 1905 Cohort Study
Longitudinal Study of Aging Danish Twins
The Longitudinal Danish Centenarian Study
552 81.8 (7.8) 7.73 kb (1.25)
Cawthon et al. (2003) 72 73.8 (8.0) 1.04 T/S (0.15) Real-time PCR Whole blood
Utah residents who gave blood, USA 71 71.8 (6.8) 1.09 T/S (0.16)
Chen et al. (2009) (Blacks) 62 39.0 (4.1) 7.55 kb (0.70) TRF Southern Blot Whole Blood
Bogalusa Heart Study, USA 128 37.0 (5.3) 7.60 kb (0.81)
Chen et al. (2009) (Whites) 208 38.5 (4.5) 7.05 kb (0.70) TRF Southern Blot Whole blood
Bogalusa Heart Study, USA 264 37.5 (4.8) 7.11 kb (0.74) TRF Southern Blot Whole blood
Cherkas et al. (2008) 247 48.1 (13.9) 6.61 kb (0.67)
(Data used from larger
Mangino et al., 2009 publication)
UK Adult Twin Registry, UK
3009 48.7 (13.0) 7.01 kb (0.68)
Cronkhite et al. (2008) 99 55.7 (16.0) 5.83 kb (0.66) TRF Southern Blot Whole blood
No details of how recruited, USA 102 55.8 (15.8) 5.97 kb (0.48)
Diez Roux et al. (2009) 467 65.4 (9.6) 0.82 T/S (0.17) Real-time PCR Whole blood
Multi-ethnic study of Atherosclerosis, USA 514 65.1 (9.9) 0.87 T/S(0.18)
Halaschek-Wiener et al. (2008) 69 78.1 (19.1) 6.49 kb (0.96) Flow-FISH Granulocytes
Population based lists, Canada 131 78.4 (18.0) 6.61 kb (0.83)
Halaschek-Wiener et al. (2008) 69 78.1 (19.1) 4.95 kb (1.20) Flow-FISH Lymphocytes
Population based lists, Canada 131 78.4 (18.0) 5.26 kb (1.34)
Hunt et al. (2008) blacks 216 52.3 (10.7) 6.95 kb (0.64) TRF Southern Blot Whole blood
Family Heart Study, USA 409 53.8 (11.0) 7.16 kb (0.63)
Hunt et al. (2008) whites 1170 56.6 (13.4) 6.70 kb (0.65) TRF Southern Blot Whole blood
Family Heart Study, USA 1433 57.4 (13.1) 6.86 kb (0.67)
Jang et al. (2008) 334 59.2 (6.2) 2.22 T/S (1.05) Real-time PCR Lymphocytes
Primary Care/GP register, Korea 152 58.7 (7.2) 2.03 T/S (1.20)
Kaplan et al. (2009) blacks 74 73.0 (5.6) 6.31 kb (0.69) TRF Southern Blot Whole blood
Cardiovascular Health Study, USA 140 72.3 (5.0) 6.62 kb (0.66)
Kaplan et al. (2009) whites 613 75.6 (5.5) 6.19 kb (0.56) TRF Southern Blot Whole blood
Cardiovascular Health Study, USA 842 74.9 (4.9) 6.38 kb (0.62)
Kimura et al. (2007) 56 55.7 (25.5) 6.02 kb (0.99) TRF Southern Blot Whole blood
Individuals Campania region, Italy 106 76.7 (25.9) 5.57 kb (1.03)
Maeda et al. (2009) 89 44.6 (10.2) 8.77 kb (1.78) TRF Southern Blot PBMC
No details of how recruited, Japan 58 43.8 (11.0) 9.54 kb (1.96)
Martin-Ruiz et al. (2005) 184 89.9 (3.2) 4.44 kb (0.92) Real-time PCR PBMC
The Leiden 85-plus study, The Netherlands 495 89.8 (2.9) 4.26 kb (0.90)
Nawrot et al. (2004) 119 42.9 (15.7) 6.78 kb (0.70) TRF Southern Blot Whole blood
Family BasedCohort, Belgiumof the Flemish Study on
Environment, Genes and Health Outcomes
152 41.7 (17.3) 6.94 kb (0.67)
Nordfjall et al. (2005) 65 57.9 (15.3) 0.70 T/S (0.29) Real-time PCR PBMC
No details of how recruited, Sweden
Healthy individuals in 49 unrelated families
69 53.4 (15.0) 0.75 T/S (0.26)
Nordfjall et al. (2009)
NSHDS cohort study, Sweden
Time 1 722 47.1 (5.6) 0.70 T/S (0.21) Real-time PCR PBMC
568 44.4 (7.0) 0.69 T/S (0.23)
Time 2 361 57.1 (5.6) 0.59 T/S (0.16) Real-time PCR PBMC
284 54.4 (6.9) 0.64 T/S (0.20)
Nordfjall et al. (2008a) 197 47.1 (14.5) 0.62 T/S (0.14) Real-time PCR PBMC
MONICA cohort study, Sweden 335 43.8 (13.0) 0.70 T/S (0.19)
Nordfjall et al. (2008b) 514 55.3 (11.7) 0.63 T/S (0.19) Real-time PCR PBMC
MDCC/Monica cohorts, Sweden 475 49.3 (13.6) 0.69 T/S (0.19)
Ren et al. (2009) 53 44.7 (27.6) 11.7 kb (1.4) TRF Southern Blot Whole blood
Healthy individuals with ancestors living in region for
≥3 generations, Tibet
52 37.2 (24.7) 11.7 kb (1.4)
Unryn et al. (2005) 51 54.2 (14.5) 7.02 kb (0.80) TRF Southern Blot PBMC
Random digit telephone dialling, Canada 74 58.4 (12.0) 7.09 kb (0.57)
Van der Harst et al. (2007) 145 66.1 (8.5) 1.09 T/S 0.32 Real-time PCR Whole blood
38 66.7 (10.3) 1.14 T/S 0.41
(continued on next page)
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Table 1 (continued)
Reference and study name or
recruitment method
Number of participants
males females
Age males
females
Telomere length
males female
Method to measure
telomere length
Cell type
University Genetic Database
Healthy non-blood related relatives of patients
with Crohn's disease, Netherlands
Woo et al. (2008) 976 72.8 (5.0) 8.81 kb (1.62) Real-time PCR Whole Blood
Health Survey recruited from community centres for
elderly and housing estates, China
1030 72.0 (5.2) 9.35 kb (2.26)
Additional datasets
HALCyon cohorts
The Hertfordshire Ageing Study (Syddall et al., 2010), UK
Wave 1 388 67.5 (2.4) 5.32 kb (1.54) Real-time PCR PBMC
269 67.5 (2.2) 5.10 kb (1.69)
Wave 2 165 76.7 (2.4) 3.86 kb (1.20) Real-time PCR PBMC
112 76.3 (2.1) 4.00 kb (1.55)
Lothian birth cohort 1921 (Deary et al., 2004)
Wave 1 210 79.1 (0.6) 4.23 kb (0.44) Real-time PCR PBMC
287 79.1 (0.6) 3.98 kb (0.36)
Wave 3 72 86.6 (0.4) 4.43 kb (0.43) Real-time PCR PBMC
74 86.6 (0.4) 4.00 kb (0.60)
(Harris et al., 2006 published but used
larger Lothian Birth Cohort 1921 dataset)
NSHD birth cohort 1946 (Kuh et al., 2011)
Age 53 1324 53.5 (0.2) 5.87 kb (1.94) Real-time PCR PBMC
1336 53.5 (0.2) 5.42 kb (1.89)
Age 60–64 501 63.3 (1.2) 4.19 kb (1.28) Real-time PCR PBMC
557 63.4 (1.1) 4.37 kb (1.33)
Der et al. (2012)
The West of Scotland, UK
Twenty-07 study
1970s cohort 362 36.6 (0.4) 0.85 T/S (0.22) Real-time PCR Whole Blood
412 36.6 (0.4) 0.87 T/S (0.20)
1950s cohort 379 56.9 (0.9) 0.77 T/S (0.18) Real-time PCR Whole Blood
469 56.9 (0.7) 0.79 T/S (0.19)
1930s cohort 235 75.9 (0.6) 0.68 T/S (0.19) Real-time PCR Whole Blood
309 76.0 (0.6) 0.71 T/S (0.18)
Huzen et al (2011) 4027 50.4 (12.9) 1.05 T/S (0.33) Real-time PCR Whole Blood
The PREVEND Study, Netherlands 4027 48.1 (12.3) 1.08 T/S (0.34)
Mangino et al. (2012) blacks 108 52.2 (8.8) 7.05 kb (0.78) TRF Southern Blot Whole Blood
HyperGEN, USA 116 54.5 (9.1) 7.07 kb (0.64)
Mangino et al. (2012) whites 612 51.9 (14.2) 6.68 kb (0.60) TRF Southern Blot Whole Blood
HyperGEN, USA 628 53.4 (13.1) 6.80 kb (0.61)
Martin-Ruiz et al. (2011) 295 85.5 (0.5) 3.32 kb (1.14) Real-time PCR PBMC
Newcastle 85+ study, UK 456 85.5 (0.4) 3.05 kb (1.06)
a Age and telomere lengths are presented as mean (standard deviation).
20 M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27et al., 2009; Kaplan et al., 2009) each had telomere length data stratified
for black and white participants and these data are presented separate-
ly. Mean age ranged from 36.6 ± 0.4SD years in The West of Scotland
Twenty-07 Study to 89.9 ± 3.2SD years in the Leiden 85+ Study. The
method of measurement of telomere length was TRF Southern Blot in
17datasets, Real-timePCR in 19 datasets and Flow-FISH in four datasets.
Telomere lengths were measured in whole blood (27 datasets), PBMC
(8 datasets), granulocytes (2 datasets) and lymphocytes (3 datasets).3.1. Meta-analyses
Overall summary estimates of effects for the associations between
gender and telomere length are detailed in Table 2. Meta-analyses
from the 36 cohorts (36,230participants) showed that genderwas asso-
ciated with telomere length, with females having longer telomeres on
average than males (standardised difference in telomere length
between females and males 0.090, 95% CI 0.015, 0.166, p = 0.02; age-
adjusted; Fig. 2). These results included the 3 HALCyon studies and
Nordfjall et al., 2009 at time 1. When these analyses were repeated
but including these 4 studies at time 2 rather than time 1 (where the
difference in mean ages between times 1 and 2 ranged from 7.5 years
to 10 years), the associations between gender and telomere length
were present, again showing that females had longer telomeres than
males (p b 0.001).3.2. Heterogeneity
There was evidence of substantial heterogeneity between studies
(I2 = 91.4%, 95% CI 89.0, 93.2, p b 0.001) (Table 2). There was little
evidence that the association between gender and telomere length var-
ied by age group (F ratio = 0.00, p = 1.00; Table 2; Fig. 3) but did vary
by the method of telomere length measurement (F ratio = 5.72,
p = 0.007; Table 2; Fig. 4). Therewasmoderate heterogeneity between
studies using the TRF Southern Blot method (I2 = 68.8%, 95% CI 48.5,
81.1, p b 0.001) and high heterogeneity between studies using the
Real-time PCR method (I2 = 93.2%, 95% CI 90.6, 95.1, p b 0.001) and
the summary estimates of effect showed longer telomeres in females
than males only for the TRF Southern Blot method. There was little
evidence that the associations between gender and telomere length
varied by cell type (F ratio = 1.31, p = 0.29; Table 2; Fig. 5). The results
in Table 2 include the 3 HALCyon studies and Nordfjall et al., 2009 at
phase 1.When these analyses were repeated but including these 4 stud-
ies at phase 2, therewas again little evidence that the associations varied
by age group (F ratio = 0.06, p = 0.80) or by cell type (F ratio = 0.99,
p = 0.41) but there was still evidence (albeit weaker) that the associa-
tion between gender and telomere length varied by method to measure
telomere length (F ratio = 3.10, p = 0.06). There was little evidence
that the association between telomere length and gender had a non-
linear variation with age (data not shown). For comparison purposes
for the TRF Southern Blot method, the overall summary estimates of
Table 2
Overall summary estimates of effect for the associations between gender and telomere length from stratified random effects meta-analyses.
Stratification Noa ESb females–males 95% CI (Age-adjusted) p-value I2 p-valuec
None 36 0.090 0.015, 0.166 0.02 91.4% b0.001
Mean aged (years)
≤55.8 18 0.091 −0.018, 0.200 0.10 92.4% b0.001
N55.8 18 0.090 −0.021, 0.210 0.11 90.2% b0.001
F ratio p-value
Overalle 0.00 1.00
Measurement method
Real-time PCR 17 −0.047 −0.167, 0.072 0.44 93.2% b0.001
TRF Southern Blot 17 0.240 0.173, 0.307 b0.001 68.8% b0.001
Flow-FISH 2 0.077 −0.016, 0.171 0.11 0.0% 0.65
F ratio p-value
Overalle 5.72 0.007
Cell Typef
Whole Blood 27 0.132 0.050, 0.215 0.002 91.9% b0.001
PBMC 6 −0.070 −0.354, 0.215 0.63 87.9% b0.001
Lymphocytes 1 −0.194 −0.461, 0.072 0.15 – –
Granulocytes 2 0.077 −0.016, 0.171 0.11 0.0% 0.65
F ratio p-value
Overalle 1.31 0.29
a Number of studies.
b Standardised regression coefficient (standardising for telomere length) representing the age-adjusted difference in telomere length between females and males. Here males are the
baseline group so that the coefficient represents the difference in telomere length for females and males. Hence if females have longer telomeres this would be positive.
c p-value is obtained from the heterogeneity χ2.
d Stratified by the mean age above and below the median age.
e Overall test for heterogeneity between subgroups by undertaking meta-regression and giving F ratio and p-values.
f Cell types are whole blood (leukocytes: lymphocytes, monocytes and granulocytes) and Peripheral Blood Mononucleocytes (PBMC: enriched for lymphocytes), lymphocytes or
granulocytes. Random effects meta-analyses were used throughout.
21M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27the absolute difference in telomere length between females and males
was 176 bp (95% CI 131, 221, p b 0.001; age-adjusted).
3.3. Publication bias
The funnel plots (data not shown) and Egger test (bias = −1.52,
p = 0.15) did not show strong evidence for small study bias.
3.4. Sensitivity analyses
We found noevidence that the association between gender and telo-
mere length differed whether we used raw data for telomere length, or
whether it was transformed (loge) (data not shown). Excluding studies
where there were no details of how the healthy participants were sam-
pled had little effect on the findings. The Egger test using these studies,
showed that there was again no strong evidence for small study bias
(bias = −1.76, p = 0.18; including phase 1 data). Repeating the anal-
yses including lymphocyte data rather than granulocyte data for the
two studies with both data made little difference to the associations
(data not shown). Replacing (Nordfjall et al., 2009) study with data
from either (Nordfjall et al., 2008a) or (Nordfjall et al., 2008b) again
had little effect on the associations. Eight out of 22 studies reported
values for intra-assay CV and 4 out of 22 studies reported values for
inter-assay CV. Repeating the analyses but including only those 10 stud-
ies who reported intra-assay or inter-assay CV in their studies, showed
that gender was strongly associated with telomere length, with females
having longer telomeres than males.
4. Discussion
4.1. Explanation of findings
The results of these meta-analyses showed that gender was associat-
ed with telomere length, with females having longer telomeres on
average than males, even though significant heterogeneity between
studies was detected. There was little evidence that the strength of theassociations varied by age group or by cell type. However, the association
between gender and telomere length did vary bymeasurementmethods.
The summary estimates of effect showed longer telomeres in females
than males only for the TRF Southern Blot method, but not for the Real-
time PCR nor the Flow-FISHmethod. However, therewas significant het-
erogeneity between studies, particularly for the Real-time PCR method
(I2 = 93.2%) but also for TRF Southern Blot (I2 = 68.8%)methodologies.
Moreover, heterogeneity was also confirmed by more recent large Real-
time PCR studies which did (Weischer et al., 2012) or did not (Needham
et al., 2013) identify shorter telomeres in males than females.
These results suggest two alternative conclusions: (i) women have
longer telomeres than men, and the failure of the PCR and Flow-FISH
methods to detect this difference reproducibly is related to higher
experimental variability of these techniques, or (ii) there is no consis-
tent gender difference in telomere length but amethodological bias spe-
cific to the Southern blot technique.
The overall outcome of the present systematic review argues in
favour of the first conclusion. In addition, a number of biological plausi-
ble arguments for longer telomeres in women than in men have been
made. These include the action of oestrogen which can stimulate the
production of telomerase and might be protective against reactive oxy-
gen species damage (Aviv, 2002) and the heterogametic sex hypothesis
(Barrett and Richardson, 2011) stating that any deleterious recessive
alleles on the X chromosome of the heterogametic sex (males in
humans (XY)), will have no compensatory allele, unlike in females
where the second chromosome might compensate (Austad, 2006).
Hence, shorter telomeres in males might arise if the unguarded X chro-
mosome in males contains inferior telomere maintenance alleles
(Barrett and Richardson, 2011).
It has been suggested that longer telomere length in women than
men might arise from a slower rate of telomere attrition in women
(Okuda et al., 2002). In both cross-sectional (Bekaert et al., 2007) and
longitudinal studies (Chen et al., 2011) the rate of leukocyte telomere
length shortening was slower in women than men. However, the asso-
ciationswere not strong and hence need to be confirmed in larger stud-
ies (Chen et al., 2011). In the present study, there was little evidence
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Overall  (I-squared = 91.4%, p = 0.000)
Mangino_2012 whites (Hypergen)
Diez Roux_2009
Martin-Ruiz_2011 (Newcastle 85+)
HAS_w1 (unpublished)
Woo_2008
Kaplan_2009 whites
Jang_2008
Study
Mangino_2012 blacks (Hypergen)
Unryn_2005
Der_2012 (1970)
Chen_2009 whites
Halaschek_2008_Gran
Cronkhite_2008
Maeda_2009
Martin-Ruiz_2005
Nordfjall_2005
Cawthon_2003
Aubert_2012_Gran
NSHD_age 53 (unpublished)
Chen_2009 blacks
Der_2012 (1930)
LBC1921_ w1 (unpublished)
Hunt_2008 whites (FHS)
Hunt_2008 blacks (FHS)
Nordfjall_2009
Kaplan_2009 blacks
Ren_2009
Adams_2007
Kimura_2007
Bischoff_2006
Der_2012 (1950)
Mangino_2009
Van der Harst_2007
Nawrot_2004
Kingma_2012 (PREVEND)
Asklepios_2007
52.7
65.2
85.5
67.5
72.4
75.2
59
Age
53.4
56.7
36.6
37.9
78.3
55.8
44.3
89.8
55.6
72.8
43.6
53.5
37.7
76
79.1
57
53.3
45.9
72.5
40.7
50
69.5
81.4
56.9
48.6
66.2
43.3
49.3
46
0.09 (0.01, 0.17)
0.27 (0.17, 0.36)
0.30 (0.18, 0.42)
-0.22 (-0.37, -0.08)
-0.13 (-0.29, 0.02)
0.26 (0.18, 0.35)
0.30 (0.20, 0.40)
-0.19 (-0.46, 0.07)
ES (95% CI)
0.04 (-0.21, 0.30)
0.24 (-0.08, 0.57)
0.13 (-0.01, 0.27)
0.07 (-0.11, 0.26)
0.14 (-0.14, 0.42)
0.24 (-0.01, 0.49)
0.42 (0.01, 0.83)
-0.20 (-0.37, -0.03)
0.07 (-0.26, 0.41)
0.23 (-0.09, 0.55)
0.07 (-0.03, 0.17)
-0.23 (-0.31, -0.16)
0.02 (-0.29, 0.33)
0.25 (0.09, 0.40)
-0.60 (-0.76, -0.43)
0.22 (0.16, 0.28)
0.40 (0.26, 0.54)
-0.07 (-0.23, 0.09)
0.41 (0.14, 0.68)
-0.18 (-0.41, 0.05)
-0.74 (-0.96, -0.51)
0.22 (0.02, 0.42)
0.20 (0.04, 0.35)
0.11 (-0.03, 0.24)
0.60 (0.45, 0.75)
0.15 (-0.19, 0.50)
0.20 (0.01, 0.39)
0.08 (0.04, 0.12)
0.23 (0.15, 0.30)
100.00
3.23
3.15
3.03
2.98
3.26
3.21
2.40
Weight
2.44
2.08
3.05
2.84
2.33
2.48
%
1.70
2.91
2.05
2.11
3.22
3.30
2.18
2.97
2.94
3.34
3.06
2.96
2.36
2.59
2.60
2.75
2.99
3.07
2.99
1.98
2.79
3.37
3.30
longer telomeres males  longer telomeres females 
0-.964 .964
Standardised difference in telomere length between females and males adjusted for age
Association between gender and telomere length
Fig. 2.Meta-analysis for the association between gender and telomere length adjusted for continuous age.
22 M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27that the strength of the association between gender and telomere
length varied by age group (above versus below the median age of
55.6 years). It is not clear whether gender dependent differences in
telomere length are already present at birth: One study found that
therewas little difference in telomere lengthmeasured by TRF Southern
Blot between the sexes at birth (Okuda et al., 2002),while a recent study
using Flow-FISH found that female newborns had longer telomeres than
males (Aubert et al., 2012).
It has been suggested that longer telomeres might be a cause of
improved fitness in women, manifest in longer lifespan and lower risk
for cardiovascular disease and cancers (Aviv, 2002). However, the
picturemight bemore complex:While short leukocyte telomere length
has been associated with cardiovascular risk factors (Benetos et al.,
2001; Bekaert et al., 2007; Fitzpatrick et al., 2007; Nordfjall et al.,
2008b; Shiels et al., 2011) and cardiovascular disease (Brouilette et al.,
2007; Fitzpatrick et al., 2007), it did not predict risk for enhanced cancer
incidence in carefully controlled prospective studies (Weischer et al.,
2013) and for some cancers including breast cancer, long rather than
short telomeres were associated with increased risk (Pellatt et al.,
2013). While males die at a higher rate at virtually every age (Austad,
2006), associations of telomere length with mortality have shown con-
tradictory results (Cawthon et al., 2003; Bischoff et al., 2006; Fitzpatrick
et al., 2011). Finally, females show higher incidence and prevalence of
many age-related diseases (except cardiovascular disease and cancer)
and disabilities (Collerton et al., 2009). Many of these including, for
example, multiple-morbidity (Sanders et al., 2012), rheumatoid arthri-
tis (Costenbader et al., 2011) or depression (Puterman et al., 2013)
have been associated with short telomeres. Together, these data donot suggest a general association between gender-specific telomere
length and fitness in domains other than cardiovascular disease.
A large part of the heterogeneity of the real-time PCR studies can be
attributed to a single group. The von Zglinicki group repeatedly reported
longer telomeres in men than in women (Deary et al., 2004; Martin-
Ruiz et al., 2005, 2011; Adams et al., 2007; Syddall et al., 2010; Kuh
et al., 2011). A post hoc analysis excluding these studies (Deary et al.,
2004; Martin-Ruiz et al., 2005, 2011; Adams et al., 2007; Syddall et al.,
2010; Kuh et al., 2011) now showed longer telomeres in females than
males for the Real-time PCR method (standardised difference in telo-
mere length between females and males 0.134, 95% CI 0.053, 0.215,
p = 0.001). However, therewas still evidence ofmoderate heterogene-
ity (e.g. Real-time PCR I2 = 72.9%). To address the possibility of meth-
odological errors, a number of methodological checks were performed
by the von Zglinicki group. Coding errorswere ruled out by independent
cross-checks. Inter-assay CV were measured repeatedly and always
found to be below 6%. PCR efficiencies were estimated both from stan-
dard curves and as single-well efficiency. Plate-to-plate efficiency varia-
tion was below 1% for the reference gene PCR and below 2.7% for
telomere PCR. The intra-plate single-well efficiency CV was always
below 3%. Finally, telomere length of the Newcastle 85+ study partici-
pants (which showed longer telomeres in men than women PBMCs)
was repeated using whole blood and a different reference gene with
the same result. Interestingly, Southern blot telomere length studies in
patient cohorts done by the von Zglinicki group showed a tendency
towards longer telomeres in women in agreement with the Southern
blot studies included in the present review (von Zglinicki et al., 2000;
Martin-Ruiz et al., 2006). Thus, there is no obvious methodological
NOTE: Weights are from random effects analysis
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23M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27explanation for the fact that the Newcastle group found longer telo-
meres in men in most of their analysed cohorts, using Real-time PCR
methodology.
Smaller measurement error in the TRF Southern Blot method as
compared to the Real-time PCR methodology might explain greater
consistency of findings between studies using the Southern blot tech-
nique (Aviv et al., 2011). In a recent blinded study (Aviv et al., 2011),
the inter-assay CVwasmuch larger (6.45%) for the Real-time PCRmeth-
od performed by the Blackburn group than that of the TRF Southern Blot
method as performed by the Aviv group (1.74%). However, this differ-
ence is probably not representative for the field as a whole. In the liter-
ature, inter-assay CV has ranged from 2.3% to 28% for Real-time PCR
methods and from 1.5% to 12% for TRF Southern Blot methods (Aviv
et al., 2011). In the studies included here, where reported, coefficient
of variation ranged from 1.7% to 11.1% for Real-time PCR and from
1.4% to 12% for TRF Southern Blot. In a fully blinded comparative telo-
mere length assessment involving 10 different groups, many of which
also contributed data to the present analysis, median inter-assay CVs
were not significantly different between techniques (p = 0.86, in prep-
aration). Excluding the data with the lowest reported CVs generated by
the Aviv group had little impact on effect size (0.174, 95% CI 0.045,
0.303, p b 0.01) or heterogeneity (I2 = 59.6%, p b 0.03) for the South-
ern blot results, although the average of the reported CVs for theremaining groups using the Southern blot technique was now 7.4%.
Therefore, differences between Southern blotting and the two other
techniques cannot be due to technology-specific randommeasurement
error.
However, our results do not rule out the possibility of technology-
specific bias. Various types of polymorphisms will have technology-
specific impact on telomere length if measured by Southern blot versus
PCR or Flow-FISH. The most probable of these are polymorphisms
affecting the most distal recognition sites for the endonucleases Hinf1
and RSA1 typically used in TRF Southern blotting. Subtelomeric regions
exhibit high levels of sequence polymorphism and strong linkage
disequilibrium, leading to the existence of relatively few common hap-
lotypes (Baird et al., 1995, 2000). The most distal Hinf1/RSA1 recogni-
tion site at chromosome Xp/Yp, for instance, is polymorphic, resulting
in an apparent increase in the length of this telomere if measured by
Southern blotting in this haplotype (Baird et al., 1995). Interstitial telo-
mere repeats are also highly polymorphic due to polymerase template
slippage, which can cause either insertion or deletion of hexameric
repeat units (Mondello et al., 2000). Both short (Ruiz-Herrera et al.,
2008) and long interstitial telomeric repeats are frequent in the
human genome, for instance an interstitial repeat at chromosome
22q11 displays length polymorphism ranging from 1 to 4 kb
(Samassekou and Yan, 2011). Such interstitial sequences will either
NOTE: Weights are from random effects analysis
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Fig. 4. Stratified meta-analyses by method of measurement of telomere length for the association between gender and telomere length adjusted for continuous age.
24 M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27not contribute to the Southern blot signal at all (short interstitial
sequences) or register as short telomere. In contrast, they will
always increase the apparent average telomere length measured by
PCR or Flow-FISH. In birds, the amount of interstitial telomeric
sequence was substantial as compared to the actual telomeres and
highly variable between species. Most importantly, it was also highly
variable between individuals (Foote et al., 2013). It is not known
whether frequencies of any of these polymorphisms might be
gender-specific in humans. Finally, Hinf1/RSA1 are not fully
methylation-insensitive, both may be blocked by overlapping CpG
methylation. Telomeres tend to be transcriptionally silenced and
hyper-methylated, however, this is a regulated process as evident
in the human ICF syndrome, where hypomethylation due to lack of
the DNA methyltransferase DNMT3b causes abnormally high levels
of telomere repeat containing RNA (TERRA) and complete failure of
telomere maintenance (Deng et al., 2010). Subtelomeric hypomethy-
lation in endothelial cells was associated with apparent telomere
lengthening as measured by Southern blot (Maeda et al., 2013). X
inactivation in females might thus be expected to skew a subpopula-
tion of telomeres towards apparently larger sizes if measured by
Southern blot. Whether subtelomeric CpG sites on other chromo-
somes are differentially methylated between the sexes is not known
but possible.4.2. Strengths and limitations
This large scale systematic review and meta-analysis examining the
association between gender and telomere length includes data from 40
datasets.We have followed a strict protocol, testing a priori hypotheses,
have included several unpublished cohorts, have standardised regres-
sion coefficients and have undertaken a series of sensitivity analyses.
We have thus aimed tominimise a range of biases including publication
and selection bias. We requested that authors performed their analyses
in a standard way, so limiting the heterogeneity caused by variation in
analysis. Furthermore, possible sources of heterogeneity include the
differences in the protocols for measuring telomere length, which
might have biased the associations. We aimed to overcome such differ-
ences by standardising the regression coefficients and by running sensi-
tivity analyses including raw telomere length data and transformed
telomere length data (loge). We adjusted for age as a potential con-
founder. Other potential confounders include race, BMI and smoking
status (Chen et al., 2011). Findings suggest leukocyte telomeres are
longer in African Americans than in whites (Hunt et al., 2008), hence
where available (Hunt et al., 2008; Chen et al., 2009; Kaplan et al.,
2009) we stratified analyses by race. Shorter telomeres have been
shown in some studies to be associated with obesity (Nordfjall et al.,
2008b) and smoking Valdes et al., 2005). Only a small number of studies
NOTE: Weights are from random effects analysis
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Fig. 5. Stratified meta-analyses by cell type for the association between gender and telomere length adjusted for continuous age.
25M. Gardner et al. / Experimental Gerontology 51 (2014) 15–27included data on BMI and smoking status and we decided against
requesting further adjustments for BMI and smoking status as this
might lead to inconsistencies in adjustments. In addition to the charac-
teristics investigated, it is possible that other factors might vary
between studies, for example epigenetic status, proinflammatory state
and pathogen challenge. All these factors interact with each other and
with telomere length (Aviv et al., 2006; Bekaert et al., 2007; Shiels,
2010; Shiels et al., 2011) and could result in heterogeneity.
We also undertook several sensitivity analyses- including a control
for measurement error by only including those studies with intra- or
inter-assay CV measures and for four studies we included telomere
lengthmeasures at phases 1 and2 (up to 10 years apart) andwe repeat-
ed the associations in separate meta-analyses at the two phases. For
each of these sensitivity analyses, gender was still associated with telo-
mere length, with females having longer telomeres than males. We did
not assess the quality of the included studies, as quality assessment in
meta-analysis of observational studies is controversial (Stroup et al.,
2000). Although this was a large systematic review and meta-analysis,
we might still have been underpowered for the sub-group analyses
and meta-regression. Hence whilst the funnel plots and formal tests
for publication bias gave no strong evidence for publication bias, these
still need to be interpreted with caution. Mean ages in the study ranged
from 36.6 ± 0.4SD years to 89.9 ± 3.2SD years, hence a limitation was
that there were few studies at younger ages. We adjusted for age as a
potential confounder but other potential confounders including BMI,smoking status and epigenetic status might have affected the strength
of the associations. Furthermore, variation in these characteristics
between the studies might result in heterogeneity.
5. Conclusion
Telomere length was longer on average in females than males and
the strength of these associations varied by measurement method but
not by age group: Southern blot was the only technique showing an
unequivocal sex difference. This difference cannot be explained by
differential random measurement error, but might be due to method-
specific bias. Direct comparison of Southern blot results with at least
one of the other methods in the same participants would help to clarify
whether there are real sex differences in telomere length.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.exger.2013.12.004.
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